You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

09 February 2017

“Knocking out” genes in cells of people living with HIV could lead to new methods of treatment, say scientists

Targeting the human genes that HIV takes over and uses to replicate could provide a new approach to HIV treatment and suppression – although more research is required.

0
02 February 2017

People living with HIV may be more at risk of diabetes

HIV as a risk factor for diabetes has long been controversial, but new evidence shows that people living with HIV have increased diabetes prevalence compared to the general population.

0
05 December 2016

13% of people living with HIV in the UK remain undiagnosed despite high standards of care

The UK has exceeded UNAIDS Fast-Track targets of getting people on treatment and virally suppressed, but falls behind on reaching those who are undiagnosed.

0
21 November 2016

Criminal case against 30 HIV-positive men dropped in the Czech Republic

Authorities in the Czech Republic have dropped their case against 30 HIV-positive gay men accused of having unprotected sex and spreading HIV – a criminal offence in the country.

0
16 November 2016

Only 11% of HIV-positive gay men in the USA screened for anal cancer

Gay men living with HIV are 37 times more likely to develop anal cancer than HIV-negative gay men, but a lack of guidelines means these men don’t get screened.

0
15 November 2016

HIV testing kit that gives instant results to launch in UK

The world’s fastest HIV testing kit is to be launched in the United Kingdom (UK) ahead of European HIV Testing Week (18-25 November).

0
14 November 2016

Norway provides PrEP for free to all those at risk of HIV

The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.

0
31 October 2016

Hope for people living with multi-drug resistant HIV

Phase III trials of the intravenous drug ibalizumab have been found to significantly reduce viral load in people living with HIV who do not respond to existing treatment.

0
14 September 2016

Europe grants marketing approval of Truvada for use as PrEP

The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.

0